Dataset Information

Online Portfolio: An Alternative to a Research Paper as a Final Assessment.

ABSTRACT: Research papers are a common end-of-semester assessment for senior-level seminars. The mid-semester switch to remote learning due to COVID-19 provided an opportunity to rethink this model and offer an alternative final assessment using a multipart online portfolio that addresses the learning goals of the course and the objectives of research paper-based final assessments. The smaller weekly tasks coupled with ongoing peer feedback reduced student stress and allowed for creativity and community building. Students responded positively to the novel assignment.

SUBMITTER: Chavis J

PROVIDER: S-EPMC8011871 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Online Portfolio: An Alternative to a Research Paper as a Final Assessment.

Chavis Jai J Wong Kelvin K Linden Monica L ML

Journal of microbiology & biology education 20210331 1

Research papers are a common end-of-semester assessment for senior-level seminars. The mid-semester switch to remote learning due to COVID-19 provided an opportunity to rethink this model and offer an alternative final assessment using a multipart online portfolio that addresses the learning goals of the course and the objectives of research paper-based final assessments. The smaller weekly tasks coupled with ongoing peer feedback reduced student stress and allowed for creativity and community b ...[more]

PMID: 33884052

Similar Datasets

Project description:IntroductionAlzheimer's disease (AD) and related dementias (ADRD) present significant health challenges. Understanding their underlying biology, advancing existing and new therapies, and enhancing care for patients and caregivers are critical priorities.MethodsThis article utilizes data from the International Alzheimer's and Related Dementias Research Portfolio (IADRP) to analyze funding patterns from the Alzheimer's Association over the past decade.ResultsAs the largest nonprofit funder of AD/ADRD research globally, the Alzheimer's Association has committed over $430 million, supporting a diverse range of studies across the entire spectrum of dementia-related science. The funding landscape has evolved, reflecting new areas of investigation and collaboration with broader research initiatives.DiscussionThis article highlights the dynamic nature of the Association's funding strategies and ongoing efforts to connect funding with additional supportive resources, thereby enhancing the overall research ecosystem Highlights As the world's largest nonprofit funder of Alzheimer's disease and dementia science, the Alzheimer's Association's funding activities are strategically designed in partnership with the global research community to address scientific gaps in our knowledge to advance research. A large part of the Association's funding portfolio depends on key partnerships and collaborations. From 2019 to 2023, the Alzheimer's Association has allocated funding for more than 850 new research studies. The diversity of areas funded is clear across the Association's portfolio. Beyond the Association's strong emphasis on supporting research through grant funding, there are also efforts to ensure the necessary ecosystem to support the career development of researchers and clinicians, maintaining ongoing support for current and future awardees, including convening and the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART).

Project description:BackgroundThe PMM Portfolio is comprised of the Paediatric Musculoskeletal Matters (PMM) website, the paediatric Gait, Arms, Legs and Spine (pGALS) app and e-learning modules (ELM). The target audiences are non-specialists in paediatric musculoskeletal medicine. Our study aimed to evaluate impact on learning and clinical practice.MethodsMixed methods (analytics, online survey, interviews) were used with PMM and ELM registered users and purposive sampling of users using international contacts within paediatrics and paediatric rheumatology. Data was analysed using descriptive statistics and qualitative techniques. A Paired T-Test compared self-rated confidence before and after use of the PMM Portfolio.ResultsThere has been wide reach for all the e-resources; PMM website (662,827 hits, 262,476 users, 214 countries, data 31st July 2020); pGALS app (12,670 downloads, 70 countries, data 31st July 2020); ELM (150 users, 30 countries, data 30th May 2019). There were 164 responses (students, trainees and health care professionals) to the survey from 25 countries. Most responders deemed the PMM Portfolio useful / very useful for their learning with significantly increased self-rated confidence in their clinical examination and reasoning skills following access to the PMM website, p = < 0.01, pGALS app, p = < 0.01 and ELM, p = < 0.01. The most popular PMM website pages related to clinical assessment techniques (especially pGALS). There was high uptake of the pGALS app and pGALS ELM especially from trainees and allied health professionals. Many clinicians reported the PMM Portfolio to be useful when used to teach others. User feedback reported that easy navigation, open access, clinical images and cases were the most valued features. User feedback highlighted need to increase awareness of the e-resources through training programmes.ConclusionsThe PMM Portfolio was developed to aid learning for clinicians who are not specialists in paediatric MSK medicine. Our evaluation demonstrates wide international reach and positive feedback on learning. The PMM Portfolio is a highly useful e-resource for paediatric rheumatologists in their teaching of others to raise awareness, facilitate early diagnosis and referral of children with suspected disease. The wide user engagement informed future PMM Portfolio development and the mixed method of evaluation is transferable to other e-resources.

Dataset Information

Online Portfolio: An Alternative to a Research Paper as a Final Assessment.

Publications

Online Portfolio: An Alternative to a Research Paper as a Final Assessment.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets